Biotech Values

[DewDiligence]

ARAY – I, too, am in with a small position. I made the decision to buy in August but waited until recently to pull the trigger because I expected the IPO lockup expiration to have a bigger impact. However, it became clear that insiders weren’t going to unload at these levels.

A stock ARAY reminds me of (although the technology is very different) is Visx, one of the two original LASIK companies. It took off like a rocket in the late 90s before the competition finally caught up and the 2002 recession muted consumers’ discretionary spending. It was eventually acquired by Advanced Medical Optics, a spin-off of Allergan.